Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators

Obesity or smoking: Which factor contributes more to the incidence of myocardial infarction? Authors' Reply.

Dicker D, Feldman BS, Benis A, Hoshen M

Revisiting the Role of BMI in the Guidelines for Bariatric Surgery.

Segal-Lieberman G, Segal P, Dicker D

[THE IMPACT OF A COMMUNITY INTERVENTION PROGRAM IN ISRAELI WORKSITES TO REDUCE THE RISK OF CARDIOVASCULAR DISEASES].

Yosefy C, Oliel N, Grosbirt A, Levy D, Gavish D, Dicker D, Viskoper R

Long-Term Outcomes of Three Types of Bariatric Surgery on Obesity and Type 2 Diabetes Control and Remission.

Dicker D, Yahalom R, Comaneshter DS, Vinker S

Mortality risk in admitted patients with diabetes mellitus according to treatment.

Akirov A, Dicker D, Shochat T, Shimon I

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB, LEADER Steering Committee, LEADER Trial Investigators

Obesity or smoking: Which factor contributes more to the incidence of myocardial infarction?

Dicker D, Feldman BS, Leventer-Roberts M, Benis A

The burden of cancer in Mexico, 1990-2013.

GĂłmez-DantĂŠs H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman-Retana O, Montero P, GonzĂĄlez-Robledo MC, Fitzmaurice C, Pain A, Allen C, Dicker DJ, Hamavid H, LĂłpez A, Murray C, Naghavi M, Lozano R

Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation.

Prabhu VV, Hong B, Allen JE, Zhang S, Lulla AR, Dicker DT, El-Deiry WS

The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death.

Crowder RN, Dicker DT, El-Deiry WS

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G, ESH-CHL-SHOT trial investigators

ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2Îą kinases.

Kline CL, Van den Heuvel AP, Allen JE, Prabhu VV, Dicker DT, El-Deiry WS

A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.

Matthew EM, Zhou L, Yang Z, Dicker DT, Holder SL, Lim B, Harouaka R, Zheng SY, Drabick JJ, Lamparella NE, Truica CI, El-Deiry WS

Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013.

Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, Li Y, Wang L, Liu Y, Yin P, Liu J, Yu S, Tan F, Barber RM, Coates MM, Dicker D, Fraser M, GonzĂĄlez-Medina D, Hamavid H, Hao Y, Hu G, Jiang G, Kan H, Lopez AD, Phillips MR, She J, Vos T, Wan X, Xu G, Yan LL, Yu C, Zhao Y, Zheng Y, Zou X, Naghavi M, Wang Y, Murray CJ, Yang G, Liang X